Log In
BCIQ
Print this Print this
 

Proquin XR, ciprofloxacin

Also known as: Ciprofloxacin GR

  Manage Alerts
Collapse Summary General Information
Company Depomed Inc.
DescriptionOnce-daily extended-release formulation of ciprofloxacin using Gastric Retention technology
Molecular Target DNA gyrase ; Topoisomerase IV
Mechanism of ActionProkaryotic replication inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,800.0M

$1,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/07/2015

$1,800.0M

$1,800.0M

0

Get a free BioCentury trial today